NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Stability of activated partial thromboplastin time (APTT) test under different storage conditions.

Author(s): Awad MA, Eldeen OA, Ibrahim HA

Publication: Hematology, 2006, Vol. 11, Page 311-5

PubMed ID: 17607579 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine the effects of storage duration and temperature on activated partial thromboplastin time (APTT) and factor VIII (FVIII) activity in plasma specimens from healthy volunteers and cardiovascular disease patients.

Conclusion of Paper

For healthy subjects, no significant changes were observed in APTT when plasma was either stored at room temperature or 4 degrees C for up to 6 hours. However, FVIII activity was significantly lower for all temperatures and storage durations compared to zero time values (p<0.05). For patients receiving heparin therapy, APTT test results increased significantly with storage at all temperatures (p<0.05).

Studies

  1. Study Purpose

    The purpose of this study was to determine the effects of storage duration and temperature on APTT and FVIII activity in plasma specimens from healthy volunteers and cardiovascular disease patients.

    Summary of Findings:

    For healthy subjects, no significant changes were observed in APTT when plasma was either stored at room temperature or 4 degrees C for up to 6 hours, but increasing APTT was observed with storage at -40 degrees C or when specimens were stored for more than 6 h at room temperature or 4 degrees C. In contrast, for cardiovascular disease patients receiving heparin therapy, APTT test results increased significantly with storage at all temperatures (p<0.05). FVIII activity in healthy patients was significantly lower for all temperatures and storage durations compared to zero time values (p<0.05).

    Biospecimens
    Preservative Types
    • None (Fresh)
    Diagnoses:
    • Normal
    • Cardiovascular Disease
    Platform:
    AnalyteTechnology Platform
    Morphology Hematology/ auto analyzer
    Protein Hematology/ auto analyzer
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Preaquisition Other drugs Unfractionated heparin therapy for 1 day
    Unfractionated heparin therapy for 2 days
    Storage Storage temperature Room temperature
    4 degrees C
    -40 degrees C
    Storage Storage duration 0 h
    6 h
    12 h
    24 h
    Biospecimen Acquisition Anticoagulant Sodium citrate
    Preaquisition Diagnosis/ patient condition Healthy
    Myocardial infarct
    Unstable angina
    After heart surgery

You Recently Viewed  

News and Announcements

  • Most Downloaded SOPs in 2024

  • New Articles on the GTEx Project are Now FREELY Available!

  • Just Published!

  • More...